World Trade Systems PLC Update on new business activity (2759A)
27 Diciembre 2017 - 1:00AM
UK Regulatory
TIDMWTS
RNS Number : 2759A
World Trade Systems PLC
22 December 2017
World Trade Systems PLC
22 December 2017
WORLD TRADE SYSTEMS PLC ("WTS plc")
UPDATE ON NEW BUSINESS ACTIVITIES
The Board of WTS plc announce their intentions to further
develop and implement their global business strategy. Since the
formation of WTS China in the middle of 2016, the main focus has
been on the successful development of the business of distributing
its heath food products in China. The Company has also communicated
the second element of its plans to expand the international side of
its business through partnership with established international
product companies to distribute those products in China. Progress
is being made on this and the strategy will evolve further into
related health care services as well as products.
On the product side the Company has previously announced a
memorandum of understating with Naturemed GmbH and is pleased to
update that an agreement has now been reached in relation to the
proposed commercialisation of its products in China. Naturemed GmbH
is a company with limited liability established in September 2016
and managed by Director Dr. med. Dhalia-Rosa Smolczyk. Naturemed
sells personal hygiene and dietary supplements manufactured from
natural plant and animal origin in compliance with the provisions
of the Medicines Act and the Pharmacy Act, in Germany and
abroad.
WTS plc has entered into an arrangement with two other German
companies related to NatureMed GmbH: Cordero GmbH & Co. KG and
Humanio GmbH. Both of these companies are linked via their
involvement in business activities associated with different stages
within the supply chain of naturopathy using active ingredients and
cell therapy.
Cordero GmbH & Co. KG is a company with limited liability,
established in April 2013, headquartered in Bingen Germany and
managed by Stephanie Dreyer. Cordero specialises in the production
of lyophilisates and cell peptides from animal material as well as
the acquisition and management of property.
Humanio GmbH is a company with limited liability established in
April 2013 and represented by Managing Director Stephanie Dreyer.
Humanio is involved in the operation of a day clinic for biological
medicine, including the provision of accommodation and meals to
patients. The Humanio institution is situated in a stately home in
Bingen which incorporates a cell therapy clinic and also an
analysis laboratory for the production of internationally
sought-after cell preparations (for which the property and IP is
owned by Cordero GmbH& Co. KG).
WTS plc has come to an arrangement with these companies to bring
clients from China to the Humanio clinic, to assist in the Chinese
food product registration for Naturemed capsules and supplements
and consequently sell these Naturemed products in the Chinese
market under the WTS brand.
WTS plc believes that through partnering with these companies,
mutually beneficial collaborations can be achieved as aligned with
the overarching vision of WTS plc as a 'gateway to China' by
expanding its portfolio of foreign health companies.
The UK headquarters has signed a new five year lease for a
permanent office establishment and will move its business office to
these expanded premises during January 2018. Additionally, WTS plc
is in discussions to house synergistic partner companies within
this headquarter office in Amersham, London, to enable increased
collaboration on joint projects which are currently being pursued
(please refer to Announcements dated 03 April 2017 and 17 May
2017).
The Board of WTS plc is actively seeking strategic synergistic
partners to diversify its income base and reduce its reliance on
the WTS China and are pleased to provide this update.
For more information, please contact the following:
World Trade Systems plc
Mr. AKM Ismail, Executive Director, akm.ismail@gmail.com
Information on WTS plc
WTS plc is a global health company headquartered in the UK with
a vision to be a 'gateway to China for foreign health food
companies. Currently WTS's main business operations are the
development, and distribution of health food products targeting
mid/high end consumers. Having previously had no business
activities for a number of years, the Company began its current
business activities in July of 2016 when WTS China was established
and began operations.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRTTBATMBATBRR
(END) Dow Jones Newswires
December 27, 2017 02:00 ET (07:00 GMT)
World Trade Systems (LSE:WTS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
World Trade Systems (LSE:WTS)
Gráfica de Acción Histórica
De May 2023 a May 2024